The Disruptive Power of Pharma AI
In the first of the Pharma Integrates Insights series, Marco Mohwinckel examines the adoption of artificial intelligence (AI) by pharmaceutical companies and sheds some light on what’s real … and what’s yet to come
Revolutionising Drug Discovery with Big Data and AI
As terabytes of healthcare data are generated that are more easily accessible to a broader range of stakeholders, Marco Mohwinckel examines whether a new age of AI-driven drug discovery is just around the corner